-
The FDA has announced two measures to inform the public about the status of manufacturers commitments to carry out further clinical studies following the FDAs approval of certain drugs and biological products.
-
The U.S. Supreme Court has ruled that Maine can continue with its efforts to implement its Maine Rx program, which was designed primarily to provide discounted prescription drugs to Maines uninsured residents.
-
The U.S. Food and Drug Administration (FDA) is warning pharmacists and consumers to beware of counterfeit atorvastatin calcium (Lipitor).
-
Older women taking combination hormone therapy had dementia twice as often as women not taking the therapy, according to a recently published study.
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) provides new clinical guidelines for hypertension prevention and management.
-
In the Pipeline
-
The U.S. Food and Drug Administration (FDA) and the National Cancer Institute (NCI) have recently announced that they will share knowledge and resources to facilitate the development of new cancer drugs and speed their delivery to patients.
-
New clinical practice guidelines for the prevention, detection, and treatment of high blood pressure recommend earlier and more aggressive intervention for control of the disease.
-
An increased risk of cervical cancer is associated with long durations of use of hormonal contraceptives.
-
There have been no randomized trials comparing surgery and radiotherapy for solitary brain metastases, nor are there well-defined guidelines for the management of these patients.